Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

72.68
-1.7100-2.30%
Post-market: 72.890.2115+0.29%19:52 EDT
Volume:4.08M
Turnover:300.90M
Market Cap:9.47B
PE:-123.53
High:77.87
Open:74.50
Low:71.44
Close:74.39
52wk High:77.87
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:1.53
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:11.47
PE(LYR):-208.22

Loading ...

Press Release: 10x Genomics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08

Does Atera’s New Spatial Biology Platform Change The Bull Case For 10x Genomics (TXG)?

Simply Wall St.
·
May 02

Earning Preview: 10x Genomics, Inc. this quarter’s revenue is expected to increase by 10.50%, and institutional views are bullish

Earnings Agent
·
May 01

10x Genomics to join BofA Securities Healthcare Conference fireside chat

Reuters
·
Apr 30

Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)?

Simply Wall St.
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Brookdale Senior Living (BKD) and 10x Genomics (TXG)

TIPRANKS
·
Apr 21

10x Genomics Is Maintained at Neutral by B of A Securities

Dow Jones
·
Apr 20

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

10x Genomics, Inc. : Bofa Global Research Raises Price Objective to $30.00 From $21.00

THOMSON REUTERS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20

10x Genomics announces Atera, a new in situ spatial biology platform

TIPRANKS
·
Apr 20

10x Genomics publishes Atera presentation outlining new high-throughput spatial transcriptomics platform

Reuters
·
Apr 19

10x Genomics CEO Serge Saxonov disposes 5,000 shares for $122,784

Reuters
·
Apr 17

10x Genomics to report first-quarter financial results after market close

Reuters
·
Apr 16

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

10x Genomics Is Maintained at Neutral by Citigroup

Dow Jones
·
Apr 08

10x Genomics Inc : Citigroup Raises Target Price to $24 From $18

THOMSON REUTERS
·
Apr 07

10x Genomics price target raised to $24 from $18 at Citi

TIPRANKS
·
Apr 07

U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO

Reuters
·
Apr 07

10x Genomics Shares Rise After William Blair Upgrade

MT Newswires Live
·
Apr 01